Stock Events

Stock Events

Creso Pharma Limited 

A$0.009000
14
+A$0.00+0% Friday 06:10

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29JanExpected
Q2 2021
Q4 2021
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q4 2023
-0.02
-0.01
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

-243.21%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
21.56MRevenue
-52.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CPH.AU. It's not an investment recommendation.
BHP Group Limited
2
BHP.AU
BetaShares NASDAQ 100
2
NDQ.AU
Telstra Group
2
TLS.AU
Cann Group Limited
2
CAN.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cronos Group
CRON
Mkt Cap1.25B
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, making it a direct competitor in the cannabinoid market.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray is a global leader in cannabis research, cultivation, production, and distribution, competing in the same space as Melodiol.
Canopy Growth
CGC
Mkt Cap449.07M
Canopy Growth Corporation is a world-leading diversified cannabis and cannabinoid-based consumer product company, directly competing with Melodiol's product offerings.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is engaged in the production, distribution, and sale of cannabis products, directly competing with Melodiol's market.
Direxion Daily CSI China Internet Index Bull 2X
CWEB
Mkt Cap0
Charlotte's Web Holdings specializes in hemp CBD extract products, competing in the cannabinoid wellness product market alongside Melodiol.

About

Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.
Show more...
CEO
William Lay
Country
Australia
ISIN
AU000000CPH2
WKN
000A421FN

Listings

MU
DE
1X8.MU
AU
AU
CPH.AU

0 Comments

Share your thoughts

FAQ

What is Creso Pharma Limited stock price today?▼
The current price of CPH.AU is A$0.01 AUD — it has increased by +0% in the past 24 hours. Watch Creso Pharma Limited stock price performance more closely on the chart.
What is Creso Pharma Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Creso Pharma Limited stocks are traded under the ticker CPH.AU.
What is Creso Pharma Limited revenue for the last year?▼
Creso Pharma Limited revenue for the last year amounts to 21.56M AUD.
What is Creso Pharma Limited net income for the last year?▼
CPH.AU net income for the last year is -52.45M AUD.
In which sector is Creso Pharma Limited located?▼
Creso Pharma Limited operates in the Lifestyle & Brands sector.
When did Creso Pharma Limited complete a stock split?▼
The last stock split for Creso Pharma Limited was on June 04, 2024 with a ratio of 1:30.
Where is Creso Pharma Limited headquartered?▼
Creso Pharma Limited is headquartered in Nedlands, Australia.